Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Mastectomy | Research article

Post treatment quality of life among Sri Lankan women with breast cancer

Authors: Ravindri Jayasinghe, Ashan Fernando, Umesh Jayarajah, Sanjeewa Seneviratne

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

Breast cancer and its treatment imposes a significant effect in the quality of life (QOL) of women. Being a developing country with contrasting social and cultural norms to the West, Sri Lankan women may have a different experience on QOL following surgical treatment of breast cancer. This study was conducted to evaluate post-treatment QOL in breast cancer patients and to determine its association with the type of surgery.

Methods

A cross sectional study was carried out. Fifty four women with non-metastatic breast cancer who underwent surgery for breast cancer at the Professorial Surgical Unit, Colombo during 2015–2018 and completed a minimum of one year follow up after surgery were invited to participate. Fifty-four women who responded were assessed using the validated EORTC QLQ-C30 and QLQ-BR23 questionnaires. Non-parametric tests were used for statistical analyses.

Results

The mean age was 59 years (range 36–81). A majority (61%, n = 35) underwent mastectomy and the rest (n = 19, 45%) breast conservation surgery (BCS). The mean QLQ-C30 score was 68.8 (range 8.3–100) and the mean scores for physical function, role function, emotional function, cognitive function, and social function were 71.4, 81.5, 77.0, 80.2, and 86.4, respectively. The mean scores for body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy, breast symptoms, arm symptoms, and hair loss assessed by the QLQ-BR23 were 76.4, 18.3, 33.3, 73.6, 30.5, 16.2, 23.4 and 32.7, respectively. No significant differences (P > 0.05) were noted in global health status, physical function, role function, emotional function, cognitive function and social function between BCS and mastectomy. QLQ-BR23 body image, sexual functioning, sexual enjoyment and future perspective also did not differ significantly (p > 0.05) between the two groups.

Conclusions

Sexual functioning and enjoyment, breast and arm symptoms and hair loss contributed to poor QOL while the impact on global health status including physical, social and emotional functions were minimal. Type of surgery did not appear to be associated with QOL. Future studies with a larger sample sizes will be helpful to further study these factors.
Appendix
Available only for authorised users
Literature
3.
go back to reference Jayarajah U, Varothayan S, Jayasinghe R, Seneviratne S: Present status of cancer burden in Sri Lanka based on GLOBOCAN estimates. South Asian J Cancer 2021, 10:In Press. Jayarajah U, Varothayan S, Jayasinghe R, Seneviratne S: Present status of cancer burden in Sri Lanka based on GLOBOCAN estimates. South Asian J Cancer 2021, 10:In Press.
4.
go back to reference Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718.CrossRef Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718.CrossRef
5.
go back to reference Basnayake O, Jayarajah U, Seneviratne S. Management of axilla in breast cancer: the past, present and the future. Sri Lanka Journal of Surgery. 2018:36(4). Basnayake O, Jayarajah U, Seneviratne S. Management of axilla in breast cancer: the past, present and the future. Sri Lanka Journal of Surgery. 2018:36(4).
6.
go back to reference Bertan FC, EKd C. Qualidade de vida e câncer: revisão sistemática de artigos brasileiros. Psico (Porto Alegre). 2009:366–72. Bertan FC, EKd C. Qualidade de vida e câncer: revisão sistemática de artigos brasileiros. Psico (Porto Alegre). 2009:366–72.
7.
go back to reference Nounou MI, ElAmrawy F, Ahmed N, Abdelraouf K, Goda S, Syed-Sha-Qhattal H: Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer 2015, 9s2:BCBCR.S29420. Nounou MI, ElAmrawy F, Ahmed N, Abdelraouf K, Goda S, Syed-Sha-Qhattal H: Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer 2015, 9s2:BCBCR.S29420.
8.
go back to reference Aaronson N. Quality of life and clinical trials. Lancet. 1995;346(8966):1–2. Aaronson N. Quality of life and clinical trials. Lancet. 1995;346(8966):1–2.
10.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI. 1993;85(5):365–76. https://doi.org/10.1093/jnci/85.5.365.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI. 1993;85(5):365–76. https://​doi.​org/​10.​1093/​jnci/​85.​5.​365.CrossRefPubMed
11.
go back to reference Fas M, Mrdo L, Ms M. Validity, reliability and understanding of the eortc-c30 and eortcBr23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352–63.CrossRef Fas M, Mrdo L, Ms M. Validity, reliability and understanding of the eortc-c30 and eortcBr23, quality of life questionnaires specific for breast cancer. Rev Bras Epidemiol. 2013;16(2):352–63.CrossRef
13.
go back to reference National Institutes of Health: Treatment of early stage breast cancer. In: NIH Consensus Development Conference: 1991; 1991. National Institutes of Health: Treatment of early stage breast cancer. In: NIH Consensus Development Conference: 1991; 1991.
14.
go back to reference Pinto A, Faiz O, Davis R, Almoudaris A, Vincent C. Surgical complications and their impact on patients’ psychosocial well-being: a systematic review and meta-analysis. BMJ Open. 2016:6(2). Pinto A, Faiz O, Davis R, Almoudaris A, Vincent C. Surgical complications and their impact on patients’ psychosocial well-being: a systematic review and meta-analysis. BMJ Open. 2016:6(2).
22.
go back to reference Fayers P, Aaronson NK, Bjordal K, Sullivan M: EORTC QLQ–C30 scoring manual: European Organisation for Research and Treatment of Cancer; 1995. Fayers P, Aaronson NK, Bjordal K, Sullivan M: EORTC QLQ–C30 scoring manual: European Organisation for Research and Treatment of Cancer; 1995.
23.
go back to reference Scott NW, Fayers P, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA: EORTC QLQ-C30 reference values manual. 2008. Scott NW, Fayers P, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA: EORTC QLQ-C30 reference values manual. 2008.
28.
go back to reference Epa T, Fernando A, Colonne S, Jayarajah U, Seneviratne S. Long term post-treatment psychological outcomes in breast cancer patients from a tertiary care surgical unit in a developing country in South Asia. Br J Surg. 2020;107:153–4. Epa T, Fernando A, Colonne S, Jayarajah U, Seneviratne S. Long term post-treatment psychological outcomes in breast cancer patients from a tertiary care surgical unit in a developing country in South Asia. Br J Surg. 2020;107:153–4.
29.
go back to reference Epa T, Fernando A, Colonne S, Jayarajah U, Seneviratne S. Long term post-treatment quality of life in breast cancer patients from a tertiary care surgical unit in a developing country in South Asia. Br J Surg. 2020;107:154–4. Epa T, Fernando A, Colonne S, Jayarajah U, Seneviratne S. Long term post-treatment quality of life in breast cancer patients from a tertiary care surgical unit in a developing country in South Asia. Br J Surg. 2020;107:154–4.
Metadata
Title
Post treatment quality of life among Sri Lankan women with breast cancer
Authors
Ravindri Jayasinghe
Ashan Fernando
Umesh Jayarajah
Sanjeewa Seneviratne
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08055-5

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine